Relationship between OKT3 administration, EBV seroconversion, and the lymphoproliferative syndrome in pediatric liver transplant recipients.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Transplantation Proceedings

• Publication date

  1991-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 1846468
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Successful retreatment of allograft rejection with OKT3.

  1989cited by this paper
• Pediatric liver transplantation: a 3-year experience.

  1989cited by this paper
• Role of epithelium in EBV persistence and pathogenesis of B-cell tumours.

  1988cited by this paper
• THE FREQUENCY OF EPSTEIN‐BARR VIRUS INFECTION AND ASSOCIATED LYMPHOPROLIFERATIVE SYNDROME AFTER TRANSPLANTATION AND ITS MANIFESTATIONS IN CHILDREN

  1988cited by this paper
• INCREASED INFECTIONS ASSOCIATED WITH THE USE OF OKT3 FOR TREATMENT OF STEROID‐RESISTANT REJECTION IN RENAL TRANSPLANTATION1 Pressented at the 6th Annual Meeting of the American Society of Transplant Physicians, May 1987, Chicago, IL

  1988cited by this paper
• Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies.

  1988cited by this paper
• Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation.

  1985cited by this paper
• Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

  1984cited by this paper
• T-lymphocyte subset interactions in the cell-mediated immune response to Epstein-Barr virus.

  1984cited by this paper
• Molecular interactions in human T cell-mediated cytotoxicity to EBV II. Monoclonal antibody OKT3 inhibits a post-killer-target recognition/adhesion step.

  1982cited by this paper
• The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation.

  1981cited by this paper

• Adoptive Immunotherapy for Infection Control Using Antigen-Specific Donor-Derived T Cells After Transplantation

  2016cites this paper
• Chapter 92 – Special Considerations for Immunosuppression in Children

  2015cites this paper
• Role of hepatitis C virus infection on lymphoproliferative disorders after non-liver transplantation.

  2015cites this paper
• GI and Liver Transplantation Pathology in Childhood

  2014cites this paper
• Posttransplantation lymphoproliferative disease: proposed imaging classification.

  2014cites this paper
• Hepatic transplantation: postoperative complications

  2013cites this paper
• Monitoring and Management of Immunosuppression in Paediatric Transplant Patients

  2012cites this paper
• Post-Transplant Lymphoproliferative Disease – PTLD

  2012cites this paper
• Early versus late outset of lymphoproliferative disorders post-heart and lung transplantation: the PTLD.Int Survey.

  2011cites this paper
• Hepatitis B virus infection has no significant role on lymphoproliferative disorders post liver transplantation: PTLD. int survey.

  2011cites this paper
• Hepatic involvement by lymphoproliferative disorders post liver transplantation: PTLD.Int. Survey

  2011cites this paper
• Non-mitogenic anti-CD3F(ab')2 monoclonal antibody: a novel approach to control herpetic stromal keratitis.

  2008cites this paper
• Post-transplant lymphoproliferative disease in liver transplantation.

  2007cites this paper
• Posttransplantation lymphoproliferative disorder—The great mimic in liver transplantation: Appraisal of the clinicopathologic spectrum and the role of Epstein‐Barr virus

  2007cites this paper
• Limitations in immunotherapy with CD3 antibodies: comment on the article by Drs. Chatenoud and Bach.

  2005cites this paper
• Sirolimus‐Induced Ulceration of the Small Bowel in Islet Transplant Recipients: Report of Two Cases

  2005cites this paper
• 76 – Special Considerations for Pediatric Immunosuppression After Liver Transplantation

  2005cites this paper
• Primary calcification in post-transplantation lymphoproliferative disorder involving the hepatic graft: an exceptional finding

  2005cites this paper
• The antiviral prophylaxis of post-transplant lymphoproliferative disorder

  2004cites this paper
• Role of donor versus recipient type Epstein-Barr virus in post-transplant lymphoproliferative disorders

  2004cites this paper
• Epstein-Barr virus (EBV) early-antigen serologic testing in conjunction with peripheral blood EBV DNA load as a marker for risk of posttransplantation lymphoproliferative disease.

  2003cites this paper
• Antigen-specific T cells for the treatment of infections after transplantation.

  2003cites this paper
• Therapy for Acute Rejection in Pediatric Organ Transplant Recipients

  2003cites this paper
• Epstein-Barr virus infection in transplant recipients: Summary of a workshop on surveillance, prevention and treatment.

  2002cites this paper
• History of pediatric liver transplantation. Where are we coming from? Where do we stand?

  2002cites this paper
• Supplemental ImmunoDot Test in Cases showing EBV VCA IgM by Enzyme Immunoassay and Investigation on the Usefulness of its Routine Application by Patients` Clinical Review

  2001cites this paper
• Lymphoproliferative disorders after liver transplantation: imaging features

  2001cites this paper
• The Role of Quantitative Epstein-Barr Virus Polymerase Chain Reaction and Preemptive Immunosuppression Reduction in Pediatric Liver Transplantation: A Preliminary Experience

  2001cites this paper
• Biliary stricture secondary to donor B‐cell lymphoma after orthotopic liver transplantation

  2001cites this paper
• Ocular involvement in patients with posttransplant lymphoproliferative disorder.

  2001cites this paper
• Liver transplantation. The pediatric challenge.

  2000cites this paper
• Use of radiation therapy in posttransplant lymphoproliferative disorder (PTLD) after liver transplantation

  2000cites this paper
• Risk of lymphoid neoplasia after cardiothoracic transplantation. a cohort study of the relation to Epstein-Barr virus.

  2000cites this paper
• The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.

  2000cites this paper
• Rapidly developing T-cell posttransplantation lymphoproliferative disorder.

  1999cites this paper
• Epstein-Barr virus infection in sixty pediatric liver graft recipients: diagnosis of primary infection and virologic follow-up.

  1999cites this paper
• Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: use of aciclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol.

  1999cites this paper
• Posttransplantation lymphoproliferative disorder in liver recipients: characteristics, management, and outcome.

  1999cites this paper
• Guidelines for immunosuppression management and monitoring after transplantation in children

  1999cites this paper
• THE ROLE OF ADOPTIVE IMMUNOTHERAPY IN THE PREVENTION AND TREATMENT OF LYMPHOPROLIFERATIVE DISEASE FOLLOWING TRANSPLANTATION

  1999cites this paper
• In vivo models for Epstein–Barr virus (EBV)‐associated B cell lymphoproliferative disease (BLPD)

  1999cites this paper
• Rational management of posttransplant lymphoproliferative disorder in pediatric recipients.

  1999cites this paper
• Posttransplantation lymphoproliferative disease in children: otolaryngologic manifestations and management.

  1999cites this paper
• Solid tumors after liver transplantation.

  1999cites this paper
• A randomized, placebo‐controlled trial with anti‐interleukin‐2 receptor antibody for immunosuppressive induction therapy after liver transplantation

  1998cites this paper
• The use of tacrolimus in pediatric liver transplantation.

  1998cites this paper
• Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.

  1998cites this paper
• Semiquantitative Epstein-Barr virus polymerase chain reaction analysis of peripheral blood from organ transplant patients and risk for the development of lymphoproliferative disease.

  1998cites this paper
• Occurrence of gammopathies and lymphoproliferative disorders in liver transplant recipients randomized to tacrolimus (FK506)- or cyclosporine-based immunosuppression.

  1998cites this paper
• Polymerase chain reaction and in situ hybridization of Epstein-Barr virus in liver biopsy specimens facilitate the diagnosis of EBV hepatitis after liver transplantation

  1998cites this paper
• Effect of cyclosporine and tacrolimus on the growth of Epstein-Barr virus-transformed B-cell lines.

  1998cites this paper
• Results of transplantation for acute and chronic hepatic allograft rejection.

  1998cites this paper
• Epstein-Barr virus infections in children after transplantation of the small intestine.

  1998cites this paper
• De novo cancer after orthotopic liver transplantation.

  1998cites this paper
• Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants.

  1998cites this paper
• Posttransplant Lymphoproliferative Disorder Presenting in the Head and Neck

  1997cites this paper
• Key features distinguishing post-transplantation lymphoproliferative disorders and acute liver rejection.

  1997cites this paper
• De novo malignancies after liver transplantation using tacrolimus‐based protocols or cyclosporine‐based quadruple immunosuppression with an interleukin‐2 receptor antibody or antithymocyte globulin

  1997cites this paper
• Post-transplant EBV induced lymphoproliferative disorders.

  1997cites this paper
• Liver transplantation: review of the literature. Part 3: Medical complications.

  1997cites this paper
• Epstein-Barr virus-associated post-transplant lympho-proliferative disease of donor origin in liver transplant recipients.

  1997cites this paper
• Epstein-Barr virus lymphoproliferative disorders after liver transplantation.

  1997cites this paper
• Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus.

  1997cites this paper
• Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children.

  1997cites this paper
• Clinical characteristics of lymphoproliferations after renal transplantation. Nantes experience

  1996cites this paper
• Transmission of Epstein – Barr Virus During Transplantation

  1996cites this paper
• Epstein-Barr virus DNA in serum after liver transplantation — surveillance of viral activity during treatment with different immunosuppressive agents

  1996cites this paper
• Posttransplantation de novo tumors in liver allograft recipients.

  1996cites this paper
• Mycophenolate mofetil in liver transplantation

  1996cites this paper
• Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.

  1996cites this paper
• Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient.

  1996cites this paper
• Conversion to tacrolimus after liver transplantation

  1996cites this paper
• Esophageal malignancy after liver transplantation in a patient with Barrett's esophagus.

  1996cites this paper
• [Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants].

  1996cites this paper
• Increased risk of lymphoproliferative disorders following the use of OKT3: Association with cumulative dose

  1996cites this paper
• The Treatment of Intractable Rejection with Tacrolimus (FK506) in Pediatric Liver Transplant Recipients

  1995cites this paper
• Renal dysfunction associated with liver transplantation.

  1995cites this paper
• Pretransplantation assessment of the risk of lymphoproliferative disorder.

  1995cites this paper
• FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.

  1995cites this paper
• A PROPOSAL OF FK506 OPTIMAL DOSING IN LIVING RELATED LIVER TRANSPLANTATIONS

  1995cites this paper
• Epstein–Barr virus–associated leiomyosarcomas in liver transplantation recipients. Origin from either donor or recipient tissue

  1995cites this paper
• Post-transplant lymphoproliferative disorder.

  1995cites this paper
• Interfaces between medical specialties Renaldysfunction associated withliver transplantation

  1995cites this paper
• Epstein‐Barr virus‐related localized hepatic lymphoproliferative disorders after liver transplantation

  1995cites this paper
• An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation.

  1995cites this paper
• Antiviral prophylaxis and the Epstein Barr virus‐related post‐transplant lymphoproliferative disorder

  1995cites this paper
• EPstein‐barr virus in inflammatory diseases of the liver and liver allografts: An in situ hybridization study

  1994cites this paper
• Lymphoproliferative Disorder Involving the Liver Following Transplantation: CT Appearance

  1994cites this paper
• OKT3 rescue for steroid-resistant rejection in adult liver transplantation.

  1993cites this paper
• Detection of Epstein-Barr virus by polymerase chain reaction in transbronchial biopsies of lung transplant recipients: evidence of infection?

  1993cites this paper
• MONOCLONAL ANTIBODIES IN PROPHYLACTIC IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION A RANDOMIZED CONTROLLED TRIAL COMPARING OKT3 AND ANTI‐IL-2 RECEPTOR MONOCLONAL ANTIBODY LO‐TACT-1

  1993cites this paper
• Epstein-Barr virus infection in liver transplantation patients: correlation of histopathology and semiquantitative Epstein-Barr virus-DNA recovery using polymerase chain reaction.

  1993cites this paper
• Hepatic allograft rejection: new developments in terminology, diagnosis, prevention, and treatment.

  1993cites this paper
• Adverse events associated with OKT3 immunosuppression in the prevention or treatment of allograft rejection

  1993cites this paper
• EPSTEIN‐BARR VIRUS SEROLOGY AND EPSTEIN‐BARR VIRUS‐ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS

  1993cites this paper
• Pediatric case of the day. Posttransplantation lymphoproliferative disorder.

  1992cites this paper
• Acute adenovirus hepatitis in liver transplant recipients.

  1992cites this paper
• [Lymphoid proliferation after organ transplantation].

  1992cites this paper
• Liver transplantation in children

  1992cites this paper
• Case 8-1992

  1992cites this paper